Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Weekly Digest
Fed. Cir.

Mylan Laboratories Limited v. Sanofi Mature IP, No. 20-1302 (Fed. Cir. Jan. 15, 2021)

Affirmed
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 20-1302
Decided
January 15, 2021
Judge
Per curiam (Rule 36)
Document
Rule 36 Judgment
Length
2 pages

NOTE: This disposition is nonprecedential. United States Court of Appeals

for the Federal Circuit MYLAN LABORATORIES LIMITED,

Appellant

v.

SANOFI MATURE IP,

Appellee

2020-1302

Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in No. IPR2016-00712.

JUDGMENT

MATTHEW R. REED, Wilson, Sonsini, Goodrich & Rosati, PC, Palo Alto, CA, argued for appellant. Also represented by GEORGE E. POWELL, III; JAD ALLEN MILLS, STEVEN WILLIAM PARMELEE, MICHAEL T. ROSATO, Seattle, WA; WENDY L. DEVINE, San Francisco, CA. DANIEL JOHN MINION, Venable LLP, New York, NY, argued for appellee. Also represented by KATHERINE ADAMS, WHITNEY LYNN MEIER, WILLIAM E. SOLANDER, MICHAEL S. SCERBO.

2THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:

Circuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

January 15, 2021 /s/ Peter R. Marksteiner

Date Peter R. Marksteiner

Clerk of Court

Text extracted from the official PDF and reflowed for reading. It is not a certified transcript — the PDF linked above is the authoritative document.

Analysis is coming soon.

A plain-English account of the issues, facts and holding, written by Patent Case Watch. The opinion itself — its full text, its PDF and everything else on this page — stays free to read for everyone, always.

Cite this opinion

Mylan Laboratories Limited v. Sanofi Mature IP, No. 20-1302 (Fed. Cir. Jan. 15, 2021).

Record ID
CAFC-20-1302-20210115
Permalink
https://patentcasewatch.com/opinions/CAFC-20-1302-20210115

No reporter citation is shown because the official source does not supply one; none is inferred here. Check the opinion and a citator before relying on this form.